Cancer incidence after total knee arthroplasty: A nationwide Finnish cohort from 1980 to 1996 involving 9,444 patients

Acta Orthopaedica Scandinavica

Volumn 70, Issue 6, 1999, Pages 609-617

  Paavolainen, Pekka ^a   Pukkala, Eero ^b   Pulkkinen, Pekka ^c   Visuri, Tuomo ^d  

^a JORVI HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d CENTRAL MILITARY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PROSTHESIS MATERIAL; TOTAL KNEE REPLACEMENT;

EID: 0033398398     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679908997851     Document Type: Article

References (64)

1. Agins H J, Alcock N W, Bansal M, Salvati E A, Wilson Jr P D, Pelliucci P M, Bullough P G. Metallic wear in failed titanium-alloy total hip replacements. A histological and quantitative analysis. J Bone Joint Surg (Am) 1988; 70: 347-56.
2. Amstutz H C, Campbell P, McKellop H, Schmalzried T P, Gillespie W J.Howie D, Jacobs J, Medley J. Metal on metal total hip replacement workshop consensus document. Clin Orthop 1996; 329S: S297-303.
3. Bago-Granell J, Aguirre-Canyadell M, Nardi J, Tallada N. Malignant fibrous histiocytoma of bone at the site of a total hip arthroplasty. A case report. J Bone Joint (Br) 1984:66:38-41.
4. Bartel D L, Bicknell V L, Wright T M. The effect of conformity, thickness and material on stresses in ultra-high molecular weight components for total joint replacement. J Bone Joint Surg (Am) 1986; 68: 1041-51.
5. Black J. Metal on metal bearings. A practical alternative to metal on polyethylene total joints? Clin Orthop 1996; 329S: S244-55.
6. Buly R L, Huo M H, Salvati E, Brien W, Bansal M. Titanium wear debris in failed cemented total hip arthroplasty. J Arthroplasty 1992; 7: 315-23.
7. Case C P, Langkamer V G, James C, Palmer M R, Kemp A J, Heap P F, Solomon L. Widespread dissemination of metal debris from implants. J Bone Joint Surg (Br) 1994; 76:701-12.
8. Coleman M P. Cancer risk from orthopaedic prostheses. Ann Clin Lab Sei 1996; 26: 139-46.
9. Cracchiolo A, Revell P. Metal concentration in synovial fluids of patients with prosthetic knee arthroplasty. Clin Orthop 1982; 170: 169-74.
10. Eckstein F S, Vogel U, Mohr W. Fibrosarcoma in association with a total knee joint prosthesis. Virchows Arch A Pathol Anat 1992; 421: 175-8.
11. Friedman R J, Black C J, Galante J O, Jacobs J J, Skinner H B. Current concepts in orthopaedic biomaterials and implant fixation. J Bone Joint Surg (Am) 1993; 75: 1086-109.
12. Gaechter A, Alroy J, Anderson G B J, Galante J, Rostoker W, Schajowicz F. Metal carcinogenesis. A study of the carcinogenic activity of solid metal alloys in rats. J Bone Joint Surg (Am) 1977; 59: 622-4.
13. Gill G S, Casey Chan K, Mills D M. 5- to 18- year followup study of cemented total knee arthroplasty for patients 55 years old or younger. J Arthroplasty 1997; 12:49-54.
14. Gillespie W J, Frampton C M A, Henderson R J, Ryan P M. The incidence of cancer following total hip replacement. J Bone Joint Surg (Br) 1988; 70: 539-42.
15. Gillespie W J, Henry D A, O'Connell D L, Kendrick S, Juszczak E, Mclnneny K, Derby L. Development of hematopoietic cancers after implantation of total joint replacement. Clin Orthop 1996; 329S: S290-6.
16. Gridley G, McLaughlin J K, Ekholm A, Klareskog L, Adami H-O, Hacker D G, Hoover R, Fraumeni Jr J F. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307-11.
17. Hamblen D L, Carter R L. Sarcoma and joint replacement (Editorial). J Bone Joint Surg (Br) 1984; 66: 625-6.
18. Harris W H. Osteolysis and particle disease in hip replacement. A review. Acta Orthop Scand 1994; 65: 113-23.
19. Havelin L I, Espehaug B, Vollset S E, Engesaeter L B, Langelend N. The Norwegian Arthroplasty register. Acta Orthop Scand 1993; 64: 245-51.
20. Hermanson T, Aro S, Bennet C L. Finland's health care system. Universal access to health care in a capitalistic democracy. JAMA 1994; 271: 1957-62.
21. Himmer O, Lootvoet L, Deprez P, Monfort L, Ghosez J-P. Angiosarcome après prothèse totale de genou. Rev Chir Orthop 1991; 77: 125-8.
22. Hood R W, Wright T M, Burstein A H. Retrieval analysis of total knee prostheses: A method and its application to 48 total condylar prostheses. J Biomed Mater Res 1983; 18: 829-42.
23. Howie D W, Rogers S D, McGee M A, Haynes D R. Biologic effects of cobalt chrome in cell and animal models. Clin Orthop 1996; 329S: S217-32.
24. Iglesias M E, Vàzquez Doval F J, Idoate F, Valentì J R, Quintanilla E. Malignant fibrous histiocytoma at the site of total knee replacement. J Dermatol Surg Oncol 1994; 20: 848-9.
25. Isomäki H, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukaemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 1978; 31: 691-6.
26. Kauppi M J, Savolainen H A, Anttila V-J, Isomäki H A. Increased risk of leukaemia in patients with juvenile chronic arthritis treated with chlorambucil. Acta Paediatr 1996; 85: 248-50.
27. Keskimäki I, Aro S. Accuracy of data on diagnoses, procedures and accidents in the Finnish Hospital Discharge Register. Int J Health Sei 1991; 2: 15-21.
28. Knutson K, Lewold S, Robertsson O, Lidgren L. The Swedish knee arthroplasty register. A nation-wide study of 30,003 knees 1976-1992. Acta Orthop Scand 1994; 65 (4): 375-86.
29. Landy M M, Walker P S. Wear of ultra-high-molecularweight polyethylene components of 90 retrieved knee prostheses. J Arthroplasty (Suppl 3) 1988:73-85.
30. Langkamer V G, Case C P, Heap P, Taylor A, Collins C, Pearse M, Solomon L. Systemic distribution of wear debris after hip replacement. A cause of concern? J Bone Joint Surg (Br) 1992; 74: 831-9.
31. Lewis J L, Askew M J, Jaycox D P. A comparative evaluation of tibial component design of total knee prostheses. J Bone Joint Surg (Am) 1982; 64: 129-34.
32. Lewold S, Olsson H, Gustafson P, Rydholm A. Overall cancer incidence not increased after prosthetic knee replacement: 14,551 patients followed for 66,622 personyears. Int J Cancer 1996; 68: 30-3.
33. Lumb G D, Sunderman F W. The problem of latency in the development of tumours following exposure to nickel compounds. Sei Total Environ 1994; 148: 185-90.
34. Mathiesen E B, Ahlbom A, Bermann G, Lindgren U. Total hip replacement and cancer. A cohort study. J Bone Joint Surg (Br) 1995; 77: 345-50.
35. Merrit K, Brown S A. Distribution of cobalt chromium wear and corrosion products and biologic reactions. Clin Orthop 1996; 329S: S233-43.
36. Miehlke R, Henke G, Ehrenbrink H. Kobalt- und Chfomkonzentrationen in der Synovialflussigkeit und im Blutserum nach Implantation von Kniegelenksendoprothesen mit Hilfe der Neutronaktivierungsanalyse. Z Orthop 1981; 119:767-8.
37. Muscat J E, Stellman S D, Wynder E L. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 1994; 74: 1847-54.
38. Nyren O, McLaughlin J K, Gridley G, Ekbom A, Johnell O, Fraumeni J F, Adami H-O. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1995; 87:28-33.
39. Paavolainen P, Hämäläinen M, Mustonen H, Slätis P. Registration of arthroplasties in Finland. A nationwide prospective project. Acta Orthop Scand (Suppl 241) 1991; 62: 27-30.
40. Paavolainen P, Slätis P, Hämäläinen M, Visuri T. Longterm results of total joint arthroplasty. Results of a 15year follow-up on a nationwide registration programme in Finland with 67,714 TJAs. National Agency for Medicines, Medical Devices Centre, Helsinki, Finland 1995.
41. Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Cancer incidence in Finnish hip replacement patients from 1980 to 1995. A nationwide cohort study involving 31,651 patients. J Arthroplasty 1999; 14: 272-80.
42. Penman H G, Ring P A. Osteosarcoma in association with total hip replacement. J Bone Joint Surg (Br) 1984; 66: 632-4.
43. Porter D, Madhoek R, Capell H. Non-Hodgkin's lymphoma in rheumatoid arthritis. Ann Rheum Dis 1991; 50: 275-6.
44. Prior P, Symmons D P M, Hawkins C F, Scott D L, Brown R. Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis 1984; 43: 128-31.
45. Pukkala E. Use of record linkage in small-area studies. In: Geographical and environmental epidemiology (eds. Elliot P, Guzik J, English D, Stern R). Oxford University Press, Oxford 1992: 125-31.
46. Pukkala E. Cancer risk by social class and occupation. A survey of 109,000 cancer among Finnish of working age. Contributions to Epidemiology and Biostatistics Vol 7. Basel, Karger 1995.
47. Rand J A, Ilstrup D M. Survivorship analysis of total knee arthroplasty. J Bone Joint Surg (Am) 1991; 73: 397-409.
48. Ritter M A, Campbell E, Paris P M, Keating E M. Longterm survival analysis of the posterior cruciate condylar total knee arthroplasty. J Arthroplasty 1989; 4: 293-6.
49. Robertsson O, Knutson K, Lewold S, Goodman S, Lidgren L. Knee arthroplasty in rheumatoid arthritis. A report from the Swedish Knee Arthroplasty Register on 4,381 primary operations. Acta Orthop Scand 1997; 68 (6): 545-53.
50. Rock M G. Toxicity oncogenesis case reports. In: Biological, material, and mechanical considerations of joint replacement (Ed. B F Morrey). Raven Press, Ltd., New York 1993: 339-51.
51. Santana V, Rose N R. Neoplastic lymphoproliferation in autoimmune disease: an updated review. Clin Immunol Immunopathol 1992; 63: 205-13.
52. Santavirta S, Konttinen Y T, Berghroth V, Eskola A, Tallroth K, Lindholm T S. Aggressive granulomatous lesions associated with hip arthroplasty. J Bone Joint Surg (Am) 1990a; 72: 252-8.
53. Santavirta S, Hoikka V, Eskola A, Konttinen Y T, Paavilainen T, Tallrot K. Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg (Am) 1990b; 72: 980-4.
54. Santavirta S, Konttinen Y T, Hoikka V, Eskola A. Immunopathological response to loose cementless acetabular components. J Bone Joint Surg (Br) 1991; 73: 38-42.
55. Scales JT. Black staining around titanium alloy prosthesesan orthopaedic enigma. J Bone Joint Surg (Br) 1991; 73: 534-6.
56. Solomon M I, Sekel R. Total hip arthroplasty complicated by a malignant fibrous histiocytoma. J Arthroplasty 1992; 7:549-50.
57. Soundry M, Walker P S, Reilly D T, Kurosawa H, Sledge C B. Effects of total knee replacement design on femoraltibial contact conditions. J Arthropalsty 1986; 1: 35-45.
58. S wann M. Malignant soft-tissue tumour at site of a total hip replacement. J Bone Joint Surg (Br) 1984; 66: 629-31.
59. Takagi M. Neutral proteinases and their inhibitors in the loosening of total hip prostheses. Acta Orthop Scand (Suppl 271) 1996; 67: 5-29.
60. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 365-9.
61. Visuri T, Koskenvuo M. Cancer risk after McKee-Farrar total hip replacement. Orhopaedics 1991; 14: 1-6.
62. Visuri T, Pukkala E, Paavolainen P, Pulkkinen P, Riska E B. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop 1996; 329S: S280-9.
63. Weber P C. Epithelioid sarcoma in association with total knee replacement. J. Bone Joint Surg (Br) 1986; 68: 824-6.
64. Zimlich R H, Del Shutte H, Spcctor M, Levesque M, Livingston B J, Jones W, Sauers W, Weaver K. In-vitro and in-vivo effect of particulate debris on TKA articulating surfaces. A Scientific Exhibition at the 1998 AAOS Meeting, New Orleans, Louisiana.